Prevalence of the metabolic syndrome in psoriasis: results from the national health and nutrition examination survey, 2003-2006
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationArch Dermatol, 2003-2006. 2011, 147(4):419-24
ÚtdrátturObjectives To estimate the prevalence of the metabolic syndrome among individuals with psoriasis and to examine the association between these 2 conditions in the general US population. DESIGN: Cross-sectional health survey of a nationally representative random sample of the noninstitutionalized civilian US population. SETTING: The National Health and Nutrition Examination Survey, 2003-2006. PARTICIPANTS: The study included 6549 participants aged 20 to 59 years. MAIN OUTCOME MEASURES: Prevalence of the metabolic syndrome defined by the revised National Cholesterol Education Program Adult Treatment Panel III definition and odds ratios for associations after adjustment for age, sex, race/ethnicity, smoking status, and C-reactive protein levels. RESULTS: The prevalence of the metabolic syndrome was 40% among psoriasis cases and 23% among controls. According to 2008 US census data, the projected number of patients with psoriasis aged 20 to 59 years with the metabolic syndrome was 2.7 million. The univariate and multivariate odds ratios for patients with psoriasis and the metabolic syndrome were 2.16 (95% confidence interval, 1.16 to 4.03) and 1.96 (1.01 to 3.77), respectively. The most common feature of the metabolic syndrome among patients with psoriasis was abdominal obesity, followed by hypertriglyceridemia and low levels of high-density lipoprotein cholesterol. CONCLUSIONS: The prevalence of the metabolic syndrome is high among individuals with psoriasis. Given the serious complications associated with the metabolic syndrome, this frequent comorbidity should be recognized and taken into account in the long-term treatment of individuals with psoriasis.
Lu00FDsingTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey.
- Authors: Choi HK, Ford ES, Li C, Curhan G
- Issue date: 2007 Feb 15
- Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.
- Authors: Ford ES, Giles WH, Dietz WH
- Issue date: 2002 Jan 16
- Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.
- Authors: Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM
- Issue date: 2012 Mar
- Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).
- Authors: Beddhu S, Kimmel PL, Ramkumar N, Cheung AK
- Issue date: 2005 Oct
- Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007.
- Authors: Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK
- Issue date: 2011 Jun